Home / Feed aggregator / Sources / Yahoo! News Search Results for chronic constipation


Syndicate content
chronic constipation - Yahoo! News Search Results
Updated: 19 hours 2 min ago

Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover

Sun, 02/05/2012 - 08:57
Sucampo Pharmaceuticals Inc. surged 42 percent over two days after reporting that its experimental medicine for opioid-induced bowel dysfunction met goals in a late-stage clinical trial.

Sucampo Gains as Bowel Drug Meets Study Goal: Washington Mover

Fri, 02/03/2012 - 11:28
Sucampo Pharmaceuticals Inc. surged for a second day after reporting that its experimental medicine for opioid-induced bowel dysfunction met goals in a late-stage clinical trial.

Press Release

Fri, 02/03/2012 - 08:10
Acorda Therapeutics Inc. Posted on:03 Feb 12 Acorda Therapeutics, Inc. (Nasdaq: ACOR ) presented data showing that treatment with dalfampridine improved motor function in a preclinical model of stroke, with treatment initiated at least four weeks following the ischemic event.

Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke

Fri, 02/03/2012 - 06:00
Acorda Therapeutics, Inc. presented data showing that treatment with dalfampridine improved motor function in a preclinical model of stroke, with treatment initiated at least four weeks following the ischemic event.

Gazette.Net: Constipation drug offers more potential for Bethesdas Sucampo

Thu, 02/02/2012 - 23:31
After a successful phase 3 clinical trial, Sucampo Pharmaceuticals of Bethesda is ready to apply for U.S. regulatory approval to market its constipation drug to people who have bowel dysfunction from taking morphine and codeine for chronic, non-cancer pain.

Ridiculous Pop Culture Conspiracy Theories

Thu, 02/02/2012 - 17:43
(Photos: Pacific Coast News, Getty Images, Flynet Picutres) Simply by being in the public eye, celebrities open themselves up to constant speculation and hearsay, and somehow the most absurd rumors take on a life of their own and become full-blown conspiracy theories. These urban legends are too far-out even for tabloids and their "sources" to report with any semblance of credibility, but enough ...

Sucampo Pharma's Lubiprostone Meets Key Goal In Phase III Trial For OBD - Update

Thu, 02/02/2012 - 10:56
Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.

Sucampo Pharma's Laxative Meets Key Goal In Phase III Trial For OBD - Update

Thu, 02/02/2012 - 04:55
Sucampo Pharmaceuticals Inc. (SCMP) and Takeda Pharmaceuticals U.S.A., Inc. announced Thursday that their drug lubiprostone, marketed under the trade name Amitiza, met the primary endpoint in a late-stage clinical trial for opioid-induced bowel dysfunction, or OBD.

Press Release

Thu, 02/02/2012 - 02:08
Sucampo Pharmaceuticals Inc. Posted on:02 Feb 12 Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial for the treatment of opioid-induced bowel dysfunction (OBD) in patients with chronic, non-cancer pain, excluding those taking methadone.

Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD)

Thu, 02/02/2012 - 01:30
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that lubiprostone met the primary endpoint in a phase 3 clinical trial fo

AstraZeneca PLC - Final Results - Part 3 of 3

Thu, 02/02/2012 - 01:03
 Development Pipeline as at 31 December 2011 Line Extensions Compound Mechanism Area Under Investigation Phase Date Commenced Phase Estimated Filing US EU Japan Emerging Cardiovascular Axanum proton pump ...

Dealing With Death: Mistakes We All Make - Research Summary

Wed, 02/01/2012 - 10:00
DEATH & DYING: Several physical and emotional changes occur as death approaches, including: excessive sleepiness and weakness while overall energy declines; breathing changes; visual and hearing changes, such as seeing people or scenes others d ...

Minister Madzorera on typhoid outbreak

Wed, 02/01/2012 - 06:53
TYPHOID is systemic bacterial disease that is characterised by insidious onset of sustained fever, headache, malaise, anorexia, a relative bradycardia, splenomegaly rose spots on the trunk, a non productive cough in the early stages of the illness and constipation of diarrhoea in adults.

Press Release

Mon, 01/30/2012 - 08:01
AMAG Pharmaceuticals Inc. Posted on:30 Jan 12 AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the completion of patient enrollment in the second of the company’s two phase III studies that comprise its global registrational program for Feraheme ® (ferumoxytol) in patients with iron-deficiency anemia (IDA) who are not candidates for oral iron, regardless of the underlying cause.

AMAG Pharmaceuticals Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader ...

Mon, 01/30/2012 - 07:30
AMAG Pharmaceuticals, Inc.  today announced the completion of patient enrollment in the second of the company’s two phase III studies that comprise its global registrational program for Feraheme® in patients with iron-deficiency anemia who are not candidates for oral iron, regardless of the underlying cause.

ASK A DOCTOR

Wed, 01/25/2012 - 23:07
Q: What causes hemorrhoids?

Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions

Wed, 01/25/2012 - 07:00
FLORHAM PARK, N.J., Jan. 25, 2012 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced results from two studies published online today in the journal Therapeutics ...

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer

Mon, 01/23/2012 - 15:11
PALATINE, IL-- - Acura Pharmaceuticals, Inc. , a specialty pharmaceutical company, announced today that it has been informed by Pfizer, Inc. that OXECTA® Tablets CII is now commercially available. OXECTA, ...

Think you're bloated by IBS? It could just be Small Intestinal Bacterial Overgrowth and it's easier to manage

Sat, 01/21/2012 - 21:23
For years Patrick Strudwick, left, was told he had IBS but he soon discovered he actually had SIBO which made him look pregnant.

Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results

Thu, 01/19/2012 - 15:00
Cubist Pharmaceuticals, Inc. today announced results for the fourth quarter and year ended December 31, 2011. The Company will host a conference call and webcast today at 5:00 p.m.
Syndicate content


Digest RC®

Digest RC® safely eliminates problems:

  • Chronic Constipation
  • IBS
  • Heartburn/GERD
  • Indigestion
  • Nausea/Upset Stomach
  • Bloating/Gas
  • Abdominal Cramping

Click here to learn more about Digest RC®

 

$14.95

DigestaMAX™

DigestaMAX™ safely eliminates problems:

  • Bloating
  • Belching
  • Nausea
  • Vomiting
  • Abdominal Cramping
  • Indigestion
  • Upper GI Distress

Click here to learn more about DigestaMAX™

 

$14.95

Boldavera™

Boldavera™ safely eliminates problems:

  • Severe Constipation

Click here to learn more about Boldavera™

 

$10.95